KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Twist Bioscience (TWST) Debt to Equity (2018 - 2026)

Twist Bioscience has reported Debt to Equity over the past 7 years, most recently at $0.03 for Q1 2026.

  • Quarterly Debt to Equity fell 3.29% to $0.03 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $0.03 through Mar 2026, down 3.29% year-over-year, with the annual reading at $0.03 for FY2025, N/A changed from the prior year.
  • Debt to Equity was $0.03 for Q1 2026 at Twist Bioscience, roughly flat from $0.03 in the prior quarter.
  • Over five years, Debt to Equity peaked at $0.03 in Q1 2025 and troughed at $0.03 in Q2 2025.
  • The 3-year median for Debt to Equity is $0.03 (2025), against an average of $0.03.
  • Year-over-year, Debt to Equity fell 0.03% in 2025 and then dropped 3.29% in 2026.
  • A 3-year view of Debt to Equity shows it stood at $0.03 in 2024, then decreased by 0.03% to $0.03 in 2025, then increased by 0.22% to $0.03 in 2026.
  • Per Business Quant, the three most recent readings for TWST's Debt to Equity are $0.03 (Q1 2026), $0.03 (Q4 2025), and $0.03 (Q3 2025).